What I Tell My Patients: Faculty Physicians and Nurses Discuss the Role of Antibody-Drug Conjugates in the Management of HER2-Expressing Cancers Across the Oncology Spectrum

Featuring perspectives from Dr Lyudmila A Bazhenova, Ms Kelly EH Goodwin, Dr Virginia Kaklamani, Ms Caroline Kuhlman, Ms Alexis N McKinney and Dr Zev Wainberg, including the following topics: Introduction (0:00) HER2 as a Therapeutic Target; Antibody-Drug Conjugates (6:15) HER2-Positive Breast Cancer (23:08) HER2-Positive Gastrointestinal Cancers (46:14) HER2-Positive Non-Small Cell Lung Cancer (1:08:14) Toxicities of Trastuzumab Deruxtecan (1:20:59) NCPD information and select publications